Latest Payments News

Atomos Limited has posted its first positive EBITDA quarter since late 2022, driven by strong sales of its flagship Ninja and Shinobi products. The company’s operational overhaul and strategic product launches set the stage for continued growth into Q2 FY26.

Breakthrough Minerals reports encouraging soil sampling results at its Errolls Gold Project in Western Australia, setting the stage for imminent reverse circulation drilling. The company maintains a solid cash position of approximately AUD 1.68 million to support exploration activities.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.

IODM Limited has reported a record-breaking first quarter for FY26, with cash receipts soaring 76% year-on-year, driven predominantly by explosive growth in its UK Education segment. The company also made strategic advances in North America and Japan, setting the stage for broader global expansion.

X2M Connect Limited kicks off FY26 with a 25% revenue surge and a significant reduction in net debt, backed by major new contracts across Asia and the Middle East.

xReality Group (XRG) has reported robust growth driven by its flagship Operator XR training system, securing a landmark $5.7 million contract with the Texas Department of Public Safety and unveiling ambitious plans for new product launches and global expansion.

xReality Group Limited delivered a record-breaking first quarter in FY26, driven by a landmark $5.7 million contract with the Texas Department of Public Safety and a rapidly growing US customer base.

Sunshine Metals Limited reported a solid cash position of AUD 5.1 million at the end of Q3 2025, supported by a strong financing inflow that offsets ongoing exploration expenditures.

Starpharma has secured two major partnership agreements with Genentech and Radiopharm Theranostics, unlocking significant upfront payments and milestone potential while advancing its clinical pipeline.

Focus Minerals reported a record gold pour in August 2025 and steady production at its Coolgardie Gold Project, supported by operational efficiencies and exploration progress.

Syntara Limited reports encouraging Phase 2a results for amsulostat in myelofibrosis, with significant symptom relief and spleen volume reduction sustained over 12 months, alongside new clinical trial initiations and a solid cash position.

Future Battery Minerals Ltd reports significant gold intercepts from its Miriam Project drilling and advances exploration at Burbanks East, while securing an option to acquire the Randalls Gold Project, reinforcing its position in Western Australia’s goldfields.